Inhibitor for protein disulfide-isomerase family A member 3 enhances the antiproliferative effect of inhibitor for mechanistic target of rapamycin in liver cancer: An in vitro study on combination treatment with everolimus and 16F16

mTOR is involved in the proliferation of liver cancer. However, the clinical benefit of treatment with mTOR inhibitors for liver cancer is controversial. Protein disulfide isomerase A member 3 (PDIA3) is a chaperone protein, and it supports the assembly of mTOR complex 1 (mTORC1) and stabilizes sign...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncol Lett
Egile Nagusiak: Kaneya, Yohei, Takata, Hideyuki, Wada, Ryuichi, Kure, Shoko, Ishino, Kousuke, Kudo, Mitsuhiro, Kondo, Ryota, Taniai, Nobuhiko, Ohashi, Ryuji, Yoshida, Hiroshi, Naito, Zenya
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: D.A. Spandidos 2021
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7681208/
https://ncbi.nlm.nih.gov/pubmed/33240434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.12289
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak